Don’t miss the latest developments in business and finance.

J&J

Separately, the company said in May it has resolved 95% of claims its baby powder was tainted with asbestos and caused mesothelioma, a type of cancer that forms in tissues around the heart and lungs

Updated On: 13 Aug 2024 | 8:18 AM IST

This Jammu and Kashmir Appropriation Bill, 2024 seeks to authorise the withdrawal of sums from the Consolidated Fund of the Union Territory for FY25

Updated On: 29 Jul 2024 | 12:32 PM IST

The suit is the latest salvo in the ongoing legal battle between J&J and former talc users, who allege the world's largest maker of health-care products hid the cancer risks of its iconic baby powder

Updated On: 18 Jun 2024 | 7:49 AM IST

Attorneys for some plaintiffs opposed the idea of a return to bankruptcy court

Updated On: 18 Oct 2023 | 11:24 PM IST

J&J is separately suing one of those experts, Jacqueline Moline, over a study she co-authored in 2019. That study was not at issue in Tuesday's decision

Updated On: 03 Oct 2023 | 10:41 PM IST

J&J shares dropped as much as 3.4% in post-market trading following the ruling. The company vowed to appeal Judge Kaplan's ruling

Updated On: 29 Jul 2023 | 7:28 AM IST

US bankruptcy law typically shields debtors from lawsuits while they reorganize in bankruptcy

Updated On: 27 Jun 2023 | 4:02 PM IST

J&J subsidiary LTL Management filed a bankruptcy plan in New Jersey late on Monday that details how the company intends to pay different types of cancer victims in a bankruptcy settlement

Updated On: 16 May 2023 | 10:06 PM IST

J&J has an $8.9 billion settlement agreement with the "vast majority" of the law firms representing talc claimants, said the company's head of litigation

Updated On: 03 May 2023 | 6:50 AM IST

Johnson & Johnson is earmarking nearly USD 9 billion to cover allegations that its baby power containing talc caused cancer, more than quadrupling the amount that the company had previously set aside to pay for its potential liability. Under a proposal announced Tuesday, a J&J subsidiary will re-file for Chapter 11 bankruptcy protection and seek court approval for a plan that would result in one of the largest product-liability settlements in U.S. history. The USD 8.9 billion that J&J would transfer to the subsidiary, LTL Management, would be payable over the next 25 years. The amount is up from the USD 2 billion that the New Brunswick, New Jersey, company set aside in October 2021. The revised amount is being backed by more than 60,000 parties that have filed lawsuits alleging harm from J&J talcum powder, according to the company. J&J isn't admitting any wrongdoing as part of the proposed settlement, a point that company executive emphasised in a Tuesday statement

Updated On: 05 Apr 2023 | 11:26 PM IST

Shares of the drugmaker were up nearly 1% at $170.28 in trading before the bell

Updated On: 24 Jan 2023 | 7:42 PM IST

The state government body also said that the use of the product may affect the health of the skin of newborn babies

Updated On: 16 Sep 2022 | 9:40 PM IST

Johnson and Johnson (J&J) has been facing several thousand lawsuits from women who claim that they developed ovarian cancer after using the product

Updated On: 30 Aug 2022 | 2:41 PM IST

(Reuters) -Johnson & Johnson said on Tuesday it would halt sale of personal care products in Russia, joining other companies that have limited their business in the country in response to its invasion of Ukraine.

Updated On: 29 Mar 2022 | 8:08 PM IST

SEC asks J&J to monitor adverse events closely for next three months

Updated On: 09 Oct 2021 | 1:22 AM IST

If authorized, J&J's booster could give millions more Americans additional protection against the coronavirus

Updated On: 05 Oct 2021 | 4:50 PM IST

India will make available 8 million doses of the Johnson and Johnson vaccine by the end of October under the Quad vaccine partnership, Foreign Secretary Harsh Vardhan Shringla on Friday informed.

Updated On: 25 Sep 2021 | 7:10 AM IST

J&J said a booster given two months after the first dose increased antibody levels four to six-fold

Updated On: 22 Sep 2021 | 2:52 AM IST

ignificant increases in antibody responses were seen in subjects ages 18 to 55 years old, and among those 65 or older who were given a lower dose of the booster.

Updated On: 25 Aug 2021 | 11:14 PM IST

Duato, 59, currently serves as vice chairman of J&J's executive committee

Updated On: 21 Aug 2021 | 12:57 AM IST